- The 2020 Solvency II Review and update on earlier amendments: European Commission issues Call for Advice
This briefing note sets out the areas covered by the European Commission’s latest request for the 2020 review of the whole Solvency II framework.
- Analysis of non-life insurers' Solvency and Financial Condition Reports: European non-life insurers year-end 2017
The analyses underlying this report focus on the quantitative information contained in the Quantitative Reporting Templates with the Solvency and Financial Condition Reports and draw conclusions about the balance sheets and risk exposures of European non-life insurers.
- Microinsurance and rural development in China: A QA with Associate Professor Yi Yao (Kitty) of Peking University
What is the microinsurance market like in China and how is it defined?
- Analysis of Dutch insurers’ Solvency and Financial Condition Reports: Year-end 2017
This report provides a summary of the key solvency information of the main life and non-life insurance entities in the Netherlands based on Solvency and Financial Condition Reports as per year-end 2017.
- Analysis of life insurers’ second set of Solvency and Financial Condition Reports: European and UK life insurers
This analysis of the European life insurance market covers 600 companies from 31 countries and one territory, representing approximately £612 billion (€691 billion) of Gross Written Premium and approximately £6,508 billion (€7,302 billion) of gross Technical Provisions.
- Analysis of Belgian insurers’ Solvency and Financial Condition Reports: Year-end 2017
This report provides a summary of Solvency and Financial Condition Reports and the main players in the Belgian market for both life and non-life undertakings.
- Analysis of insurers’ Solvency and Financial Condition Reports
This analysis compares information provided in the Quantitative Reporting Templates and the Solvency and Financial Condition Reports and draws conclusions about the balance sheets and risk exposures of European health insurers.
- IFRS 17: Considerations for health insurers
While IFRS 17 aims to bring increased transparency in the financial reporting by insurers, the complexities related to some aspects of it need to be carefully considered for short-term health insurers when esimating the financial, operational and business impact within the organisation’s governance frameworks.
- Shareholder value reporting in Europe: Year-end 2017
This publication focuses on European embedded value results at year-end 2017.
- The cyber risk spend: How do you quantify the cost of cyber risk – and your return on investment?
As cyber evolves as a threat, companies are facing an increasingly complex enterprise risk management process: the need to not only assess the risk associated with an attack, but also quantify the potential cost of this risk in order to make sure the exposure is both fully protected and efficiently and accurately budgeted.